Correlation Between Vaxart and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaxart and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and Elicio Therapeutics, you can compare the effects of market volatilities on Vaxart and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and Elicio Therapeutics.

Diversification Opportunities for Vaxart and Elicio Therapeutics

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vaxart and Elicio is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Vaxart i.e., Vaxart and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Vaxart and Elicio Therapeutics

Given the investment horizon of 90 days Vaxart is expected to generate 9.5 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Vaxart Inc is 1.4 times less risky than Elicio Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  625.00  in Elicio Therapeutics on November 18, 2024 and sell it today you would earn a total of  192.00  from holding Elicio Therapeutics or generate 30.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vaxart Inc  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Vaxart Inc 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxart Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Vaxart unveiled solid returns over the last few months and may actually be approaching a breakup point.
Elicio Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Vaxart and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaxart and Elicio Therapeutics

The main advantage of trading using opposite Vaxart and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Vaxart Inc and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges